Addiction Treatment - Articles - Page 15

An Unexpected Opioid: Loperamide Misuse

May 21, 2021

Mara Storto, MD. and Deepti Anbarasan, MD.

Mara Storto, MD. Psychiatric Resident, Psychiatry Residency Training Program, New York University Langone Health, New York, NY. Deepti Anbarasan, MD. Clinical Assistant Professor of Psychiatry, New York University, New York, NY. Dr. Storto and Dr. Anbarasan have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We normally think of loperamide as an over-the-counter drug with a good safety profile. And it is, but only when used as directed. Recreational misuse of loperamide is on the rise with some dangerous collateral effects.

A Psychosocial Intervention for Chronic Pain and SUD

May 21, 2021

David A. Moltz, MD.

David A. Moltz, MD. Dr. Moltz has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Does marijuana use reduce pain and improve quality of life over time? This observational, uncontrolled trial suggests it might, but also identifies the need for more rigorous future studies.

CME Post-Test - Stimulant Use Disorder, CATR, May/June 2021

May 21, 2021

By successfully completing the test you will be awarded a certificate for 1 CME credit.

Learning Objectives, Stimulant Use Disorder, CATR, May/June 2021

May 21, 2021

After reading these articles, you should be able to…

The Other Pandemic

March 19, 2021

Predictions that overdose mortality would worsen during the COVID-19 pandemic have unfortunately proven accurate. Recent data outlined in an alert by the CDC show that rates of overdose deaths from opioids and stimulants have accelerated at an alarming rate.

CLINICAL UPDATE

Perioperative Pain Management in Opioid Use Disorder

March 19, 2021

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Previously, clinicians commonly stopped opioid agonists (methadone and buprenorphine) to simplify pain control during and after surgery. New guidance from the American Society of Addiction Medicine now suggests otherwise.

Integrating Medication Prescribing and Psychotherapy

March 19, 2021

Carla Marienfeld, MD

Carla Marienfeld, MD

Professor of Psychiatry, University of California, San Diego. Director of the UCSD Addiction Psychiatry Fellowship, co-editor of Motivational Interviewing for Clinical Practice, and editor of Absolute Addiction Psychiatry Review. Dr. Marienfeld has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Marienfeld shares strategies of how to turn short clinical appointments meant “only” for medication management into rich therapeutic interactions. She outlines specific techniques drawn from Motivational Interviewing and Cognitive Behavioral Therapy that you can start implementing in office visits right away

Management of Opioid Withdrawal in the Emergency Setting

March 19, 2021

Rehan Aziz, MD.

Rehan Aziz, MD. Associate Professor of Psychiatry and Neurology, Rutgers Robert Wood Johnson Medical School. Dr. Aziz has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

An emergency department visit can be a “reachable moment” for people with unhealthy opioid use. Here, we review pharmacologic and harm-reduction strategies for use in those settings—and how to advocate for your patients when consulting with emergency clinicians.